GNQ Insilico Launches Revolutionary AI-Driven Assessment Platform to Transform Precision Medicine and Drug Development
Multi-Agentic AI Platform Powered by Proprietary Systems Biology Engine Delivers Personalized Therapy Optimization and Investment Risk Assessment PLEASANTON, CA, UNITED STATES, September 10, 2025 /EINPresswire.com/ — GNQ Insilico Inc. (“GNQ” or “the Company”), a pioneering TechBio firm leveraging exponential technologies for precision medicine, announces the official launch of its groundbreaking deep tech Drug Assessment Platform […]